Updating the genetics of systemic sclerosis

Area of Science:

• Genetics
• Immunology
• Rheumatology

Background:

• Systemic sclerosis (SSc) is a severe connective tissue disease marked by microangiopathy, immune dysregulation, and excessive collagen deposition.
• SSc poses a significant medical challenge due to its poor prognosis and complex pathogenesis.
• Molecular biology advances have illuminated genetic predispositions and immune mechanisms underlying SSc.

Purpose of the Study:

• To review recent large candidate gene studies and genome-wide approaches investigating SSc susceptibility genes.
• To synthesize current understanding of the genetic and immune basis of systemic sclerosis.
• To highlight recent findings in SSc genetic research.

Main Methods:

• Review of recent large candidate gene studies with replication.
• Analysis of very recent genome-wide association studies (GWAS).
• Examination of genetic associations within immune, vascular, and fibrotic pathways.

Main Results:

• Significant associations identified with immune system genes, including major histocompatibility complex (MHC) genes.
• Evidence suggests roles for genes in innate immunity, T-cell differentiation, and immune signaling.
• Associations with vascular or fibrotic factors were less consistent or not replicated.

Conclusions:

• Molecular tools have elucidated SSc susceptibility genes and pathophysiology.
• Postgenomic studies are needed to further clarify gene functions.
• Anticipated improvements in diagnostics, prognostics, and targeted immune therapies for SSc.